News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Retrospective Analysis on Galderma Laboratories’ Differin® Gel, 0.3% in Adult Female Acne Patients


8/1/2013 11:23:11 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FORT WORTH, Texas--(BUSINESS WIRE)--Galderma Laboratories, L.P. today announced results from a new analysis showing that Differin® (adapalene) Gel, 0.3%, a single agent retinoid, is efficacious in reducing acne lesions in adult women, and has been proven superior in reducing inflammatory lesions in women compared with vehicle gel.1 The data were presented today at the American Academy of Dermatology 2013 Summer Meeting in New York.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   
Acne

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES